QMS Medical

42
Sell
  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0FMW01018
  • NSEID: QMSMEDI
  • BSEID:
INR
91.00
-0.35 (-0.38%)
BSENSE

Dec 29

BSE+NSE Vol: 6000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 18.62% vs 17.38% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 27.11% vs 61.97% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 90.56% vs 36.60% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 15.75% vs 41.14% in Mar 2024

Compare Profit and Loss Results of QMS Medical
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
144.00
15.00
129.00
860.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
144.00
15.00
129.00
860.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
81.00
4.00
77.00
1,925.00%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
7.00
5.00
2.00
40.00%
Operating Expenses
6.00
0.00
6.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
0.00
4.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
14.00
3.00
11.00
366.67%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
121.00
20.00
101.00
505.00%
Operating Profit (PBDIT) excl Other Income
23.00
-5.00
28.00
560.00%
Other Income
0.00
17.00
-17.00
-100.00%
Operating Profit (PBDIT)
23.00
12.00
11.00
91.67%
Interest
5.00
3.00
2.00
66.67%
Profit before Depriciation and Tax
17.00
8.00
9.00
112.50%
Depreciation
3.00
2.00
1.00
50.00%
Profit Before Taxation & Exceptional Items
14.00
5.00
9.00
180.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
14.00
5.00
9.00
180.00%
Provision for Tax
4.00
1.00
3.00
300.00%
Profit After Tax
10.00
3.00
7.00
233.33%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
30.00
-237.00
267.00
112.66%
Profit Available for appropriations
40.00
-233.00
273.00
117.17%
Appropriations
40.00
-233.00
273.00
117.17%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
5.84
1.7
4.14
243.53%
Profit And Loss - Net Sales
Net Sales 144.87 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.62% vs 17.38% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.32 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 27.11% vs 61.97% in Mar 2024

Profit And Loss - Interest
Interest 5.96 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 90.56% vs 36.60% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 10.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.75% vs 41.14% in Mar 2024